A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system

International Journal of Pharmaceutics

Volumn 412, Issue 1-2, 2011, Pages 106-114

  Kibria, Golam ^a   Hatakeyama, Hiroto ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Anthrax toxin; Cell penetrating peptide; Dual ligand; Liposomes; Tumor endothelial marker 8

Indexed keywords

AMINO ACID; ANTHRAX TOXIN; ANTIGEN; CELL PENETRATING PEPTIDE; CLATHRIN; KYND PEPTIDE; LIPOSOME; PROTECTIVE ANTIGEN; TUMOR ENDOTHELIAL MARKER 8; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL LINE; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; LIPID MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN SYNTHESIS;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; CELL LINE; CELL-PENETRATING PEPTIDES; CELLS, CULTURED; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; LIGANDS; LIPOSOMES; MICE; NEOPLASM PROTEINS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RECEPTORS, CELL SURFACE; RECEPTORS, PEPTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 79957482249     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.010     Document Type: Article

References (44)

1. K.A. Bradley, J. Mogridge, M. Mourez, R.J. Collier, and J.A. Young Identification of the cellular receptor for anthrax toxin Nature 414 2001 225 229 (Pubitemid 33051239)
2. F. Brossier, J.C. Sirard, C. Guidi-Rontani, E. Duflot, and M. Mock Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen Infect. Immun. 67 1999 964 967 (Pubitemid 29059244)
3. D.K. Chang, C.Y. Chiu, S.Y. Kuo, W.C. Lin, A. Lo, Y.P. Wang, P.C. Li, and H.C. Wu Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors J. Biol. Chem. 284 2009 12905 12916
4. A. Corti, and M. Ponzoni Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs Ann. N. Y. Acad. Sci. 1028 2004 104 112 (Pubitemid 40361814)
5. F. Danhier, B. Vroman, N. Lecouturier, N. Crokart, V. Pourcelle, H. Freichels, C. Jérôme, J. Marchand-Brynaert, O. Feron, and V. Préat Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel J. Control. Release 140 2009 166 173
6. I. Dijkgraaf, J.A. Kruijtzer, S. Liu, A.C. Soede, W.J. Oyen, F.H. Corstens, R.M. Liskamp, and O.C. Boerman Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides Eur. J. Nucl. Med. Mol. Imaging 34 2007 267 273 (Pubitemid 46147510)
7. S.L. Du, H. Pan, W.Y. Lu, J. Wang, J. Wu, and J.Y. Wang Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats J. Pharmacol. Exp. Ther. 322 2007 560 568 (Pubitemid 47105790)
8. A. El-Sayed, S. Futaki, and H. Harashima Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment AAPS J. 11 2009 13 22
9. S.V. Garde, A.J. Forté, M. Ge, E.A. Lepekhin, C.J. Panchal, S.A. Rabbani, and J.J. Wu Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects Anticancer Drugs 18 2007 1189 1200 (Pubitemid 47480744)
10. S.H. Hansen, K. Sandvig, and B. van Deurs Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification J. Cell Biol. 121 1993 61 72 (Pubitemid 23097362)
11. H. Hatakeyama, H. Akita, E. Ishida, K. Hashimoto, H. Kobayashi, T. Aoki, J. Yasuda, K. Obata, H. Kikuchi, T. Ishida, H. Kiwada, and H. Harashima Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes Int. J. Pharm. 342 2007 194 200 (Pubitemid 47259319)
12. J.E. Heuser, and R.G. Anderson Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation J. Cell Biol. 108 1989 389 400 (Pubitemid 19065841)
13. L.J. Hewlett, A.R. Prescott, and C. Watts The coated pit and macropinocytic pathways serve distinct endosome populations J. Cell Biol. 124 1994 689 703 (Pubitemid 24085779)
14. O. Ishida, K. Maruyama, H. Tanahashi, M. Iwatsuru, K. Sasaki, M. Eriguchi, and H. Yanagie Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 2001 1042 1048 (Pubitemid 32799953)
15. P. Keim, and K.L. Smith Bacillus anthracis evolution and epidemiology Curr. Top. Microbiol. Immunol. 271 2002 21 32 (Pubitemid 34847393)
16. I.A. Khalil, S. Futaki, M. Niwa, Y. Baba, N. Kaji, H. Kamiya, and H. Harashima Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation Gene Ther. 11 2004 636 644 (Pubitemid 38455982)
17. K. Kogure, R. Moriguchi, K. Sasaki, M. Ueno, S. Futaki, and H. Harashima Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method J. Control. Release 98 2004 317 323 (Pubitemid 38950740)
18. C. Lamaze, and S.L. Schmid The emergence of clathrin-independent pinocytic pathways Curr. Opin. Cell Biol. 7 1995 573 580
19. D.D. Lasic Doxorubicin in sterically stabilized liposomes Nature 380 1996 561 562
20. A.M. Minisini, C. Andreetta, G. Fasola, and F. Puglisi Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer Expert Rev. Anticancer Ther. 8 2008 331 342 (Pubitemid 351836282)
21. D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman, and J.B. Rothbard Polyarginine enters cells more efficiently than other polycationic homopolymers J. Pept. Res. 56 2000 318 325
22. D. Mudhakir, H. Akita, E. Tan, and H. Harashima A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway J. Control. Release 125 2008 164 173 (Pubitemid 350299613)
23. Y. Nakamura, K. Kogure, S. Futaki, and H. Harashima Octaarginine-modified multifunctional envelope-type nano device for siRNA J. Control. Release 119 2007 360 367 (Pubitemid 46770881)
24. K. Ogawara, K. Un, K. Tanaka, K. Higaki, and T. Kimura In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells J. Control. Release 133 2009 4 10
25. F. Pastorino, C. Brignole, D. Marimpietri, M. Cilli, C. Gambini, D. Ribatti, R. Longhi, T.M. Allen, A. Corti, and M. Ponzoni Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy Cancer Res. 63 2003 7400 7409 (Pubitemid 37413482)
26. A.T. Perez, G.H. Domenech, C. Frankel, and C.L. Vogel Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network Inc., experience Cancer Invest. 20 2002 22 29 (Pubitemid 35303440)
27. C. Petosa, R.J. Collier, K.R. Klimpel, S.H. Leppla, and R.C. Liddington Crystal structure of the anthrax toxin protective antigen Nature 385 1997 833 838 (Pubitemid 27106075)
28. A. Puri, K. Loomis, B. Smith, J.H. Lee, A. Yavlovich, E. Heldman, and R. Blumenthal Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Crit. Rev. Ther. Drug Carrier Syst. 26 2009 523 580
29. J.B. Rothbard, E. Kreider, K. Pattabiraman, E.T. Pelkey, C.L. VanDeusen, L. Wright, B.L. Wylie, and P.A. Wender Cell-Penetrating Peptides: Processes and Applications 2002 CRC Press Florida pp. 141-160
30. T. Sakakibara, F.A. Chen, H. Kida, K. Kunieda, R.E. Cuenca, F.J. Martin, and R.B. Bankert Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts Cancer Res. 56 1996 3743 3746 (Pubitemid 26272023)
31. H.M. Scobie, and J.A. Young Interactions between anthrax toxin receptors and protective antigen Curr. Opin. Microbiol. 8 2005 106 112 (Pubitemid 40203233)
32. N. Sekiya, and A. Imamura Doxil - pegylated liposomal doxorubicin Gan. To. Kagaku. Ryoho. 35 2008 1439 1443
33. Y. Singh, K.R. Klimpel, C.P. Quinn, V.K. Chaudhary, and S.H. Leppla The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity J. Biol. Chem. 266 1991 15493 15497 (Pubitemid 21907675)
34. S.M. Stephenson, P.S. Low, and R.J. Lee Folate receptor-mediated targeting of liposomal drugs to cancer cells Methods Enzymol. 387 2004 33 50
35. R. Suzuki, T. Takizawa, Y. Kuwata, M. Mutoh, N. Ishiguro, N. Utoguchi, A. Shinohara, M. Eriguchi, H. Yanagie, and K. Maruyama Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome Int. J. Pharm. 346 2008 143 150 (Pubitemid 350101994)
36. R. Suzuki, Y. Yamada, and H. Harashima Efficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano device Biol. Pharm. Bull. 30 2007 758 762 (Pubitemid 46571006)
37. K. Takara, H. Hatakeyama, N. Ohga, K. Hida, and H. Harashima Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake Int. J. Pharm. 396 2010 143 148
38. P.C. Turnbull Introduction: anthrax history, disease and ecology Curr. Top. Microbiol. Immunol. 271 2002 1 19 (Pubitemid 34847392)
39. M. Varughese, A.V. Teixeira, S. Liu, and S.H. Leppla Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin Infect. Immun. 67 1999 1860 1865 (Pubitemid 29144407)
40. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U.S.A. 97 2000 13003 13008
41. E. Werner, A.P. Kowalczyk, and V. Faundez Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton J. Biol. Chem. 281 2006 23227 23236
42. H.C. Wu, and D.K. Chang Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy J. Oncol. 2010 2010 723798
43. A. Yamada, Y. Taniguchi, K. Kawano, T. Honda, Y. Hattori, and Y. Maitani Design of folate-linked liposomal doxorubicin to its antitumor effect in mice Clin. Cancer Res. 14 2008 8161 8168
44. J.A. Young, and R.J. Collier Anthrax toxin: receptor binding, internalization, pore formation, and translocation Annu. Rev. Biochem. 76 2007 243 265